Detalhe da pesquisa
1.
Outcomes from a mechanistic biomarker multi-arm and randomised study of liposomal MTP-PE (Mifamurtide) in metastatic and/or recurrent osteosarcoma (EuroSarc-Memos trial).
BMC Cancer
; 22(1): 629, 2022 Jun 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35672690
2.
Functional evolution of IGF2:IGF2R domain 11 binding generates novel structural interactions and a specific IGF2 antagonist.
Proc Natl Acad Sci U S A
; 113(20): E2766-75, 2016 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-27140600
3.
Sclerostin expression in bone tumours and tumour-like lesions.
Histopathology
; 69(3): 470-8, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26896083
4.
Challenges and solutions to system-wide use of precision oncology as the standard of care paradigm.
Camb Prism Precis Med
; 2: e4, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38699518
5.
Functional evaluation of novel soluble insulin-like growth factor (IGF)-II-specific ligand traps based on modified domain 11 of the human IGF2 receptor.
Mol Cancer Ther
; 6(2): 607-17, 2007 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-17308058